Central Nervous System Agents in Medicinal Chemistry
Title: Editorial
Volume: 11 Issue: 1
Author(s): Maria L Lopez-Rodriguez
Affiliation:
Export Options
About this article
Cite this article as:
L Lopez-Rodriguez Maria, Editorial, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/187152411794961059
DOI https://dx.doi.org/10.2174/187152411794961059 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenomics and Sepsis-Induced Renal Failure: Effects of β 2-Adrenoceptor Function on the Course of Sepsis
Current Pharmacogenomics and Personalized Medicine Modulation of Eating by Central Catecholamine Systems
Current Drug Targets Cognitive Behavioral Approaches for Treating Suicidal Behavior in Adolescents
Current Psychiatry Reviews Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Protective Role of <i>Morus nigra</i> Leaf Extracts against Murine Infection with <i>Eimeria papillata</i>
Combinatorial Chemistry & High Throughput Screening Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
Current Psychopharmacology Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes
Combinatorial Chemistry & High Throughput Screening Strategies for the Synthesis of Hydroxamic Acids
Current Organic Synthesis Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People
Current Pharmaceutical Design Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
Current Cardiology Reviews Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design Preconditioning with Chronic Cerebral Hypoperfusion Reduces a Focal Cerebral Ischemic Injury and Increases Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 and Matrix Metalloproteinase-2 Expression
Current Neurovascular Research Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Current Neuropharmacology Methylphenidate (Ritalin): What Makes it so Widely Prescribed During the Last 60 Years?
Current Drug Therapy Treatment of Takotsubo Cardiomyopathy
Current Pharmaceutical Design Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Drug-Associated Mitochondrial Toxicity and its Detection
Current Medicinal Chemistry